glutathione parkinsons disease therapy perlmutter Parkinson's Treatment Evolving Landscape of Parkinson's Disease
Description
Oral AOD 9604 formulations exist but have significantly lower bioavailability than subcutaneous injection
doi: 10.7326/0003-4819-130-12-199906150-00003
GSH also inhibits ROS production and prevents various subsequent protein and lipid damage
Studies and anecdotal reports suggest that it may improve muscle growth and reduce fat
sabdariffa calyx are used to treat hyperlipidemia and HTN, with no reported adverse events or side effects
